Stiefel, a GSK company, has acquired the development and commercialization rights to Welichem Biotech (WBI) anti-inflammatory agent, WBI-1001. The acquisition follows the previously announced asset purchase agreement. WBI-1001 ...
Tags: acquisition, clinical drugs, Stiefel
Ventana Medical Systems has received FDA approval for the application of its INFORM HER2 Dual ISH DNA Probe cocktail assay (HER2 Dual ISH) on the BenchMark ULTRA automated slide staining platform. The BenchMark XT instrument, the HER2 ...
Saladax Biomedical has signed a distribution contract with INyDIA Labs for My5-FU, a test that measures levels of 5-fluorouracil (5-FU), in the blood of cancer patients, in Spain and Protugal. INyDIA will provide My5-FU test kits to ...
Tags: medical research, medical test, clinical research, company collaboration
Saladax Biomedical has signed a diagnostic agreement with Eilaf Pharma for My5-FU diagnostic test in Egypt and throughout the Middle East North African (MENA) region. The test will measure the levels of an anti-cancer drug, ...
Tags: My5-FU diagnostic test, medical research, medical test
The cancer genetic testing services provider, NeoGenomics has launched the first molecular assay, NeoType CLL for clinical use in the US, which detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1). The assay will offer ...
Tags: molecular assay, clinical research, clinical development
CIGNA & CMC Life Insurance, a joint venture between CIGNA and China Merchants Group, has introduced a new health insurance product to provide high quality health coverage in China. Dubbed Pearl Plan, the product further expands the ...
Tags: insurance, health insurance, insurance service, insurance product
BioView and Abbott have entered into a partnership agreement for the development of automated scanning solution to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in patients with advanced non-small cell lung cancer ...
Tags: BioView, Abbott, automated scanning solution, NSCLC
MDxHealth and PLUS Diagnostics have reached an agreement to co-promote MDxHealth's ConfirmMDx for prostate cancer in the US. ConfirmMDx is a laboratory-developed test (LDT), which assists urologists with identifying men who may safely ...
Tags: prostate cancer assay, cancer assessment, clinical research
HTG Molecular Diagnostics has collaborated with John Wayne Cancer Institute (JWCI) to market its HTG melanoma signature assays. The signature assays may be useful for diagnostic and prognostic applications along the melanoma ...
Tags: HTG melanoma signature assays, clinical technology, clinical research
New York College of Health Professions doesn't have a sports team, but it is about to make sports history with the development of a new line of functional acupressure clothing and accessories called MyChi. The line, which can help athletes ...
Tags: acupressure clothing, health, clothing line
Phenogen Sciences has announced the availability of BREVAGen Breast cancer risk assessment test for women at above average risk of developing estrogen-receptor positive breast cancer. The risk assessment test, which combines clinical ...
Tags: medical research, clinical technology, risk assessment test
RayBiotech-developed antibody-based biomarker screening assays have been used to identify a critical pathway involved in chemotherapeutic resistance acquired by melanoma cancer cells. RayBiotech president and chief operating officer ...
Tags: medical research, clinical technology, RayBiotech's antibody arrays
Medivation and Astellas Pharma have launched Xtandi (enzalutamide) capsules for patients with metastatic castration-resistant prostate cancer who have previously received docetaxel. Xtandi, an oral, once-daily androgen receptor inhibitor ...
TNI BioTech and Hubei Qianjiang Pharmaceutical have entered into a partnership to develop new cancer therapeutics. The cancer drugs will be based on TNI BioTech's patents covering Methionine Enkephalin. TNI BioTech will carry out ...
Tags: Hubei Qianjiang Pharmaceutical, cancer drugs, methionine enkephalin
Selcia Limited has launched a new platform that enables drug discovery and development on the target family of peptidyl-prolyl cis-trans isomerases (PPIases). The scope of the service includes drug screening, functional assays, compound ...
Tags: Selcia Limited, PPIases, drug screening, functional assays